Template:Anthrax antibiotics: Difference between revisions
No edit summary |
|||
| Line 11: | Line 11: | ||
*[[Ciprofloxacin]] 400mg IV q12hrs x 60 days (1st line) '''OR''' | *[[Ciprofloxacin]] 400mg IV q12hrs x 60 days (1st line) '''OR''' | ||
*[[Doxycycline]] 100mg IV q12hrs x 60days (only if allergic to ciprofloxacin) '''PLUS''' | *[[Doxycycline]] 100mg IV q12hrs x 60days (only if allergic to ciprofloxacin) '''PLUS''' | ||
**[[Clindamycin]] | **[[Clindamycin]] 900mg IV q8hrs | ||
====Pediatric Postexpsoure Prophylaxis==== | ====Pediatric Postexpsoure Prophylaxis==== | ||
Revision as of 18:43, 2 October 2019
Postexposure Prophylaxis
Patient should be vaccinated at day #0, #14, #28
- Ciprofloxacin 500mg PO q12hrs daily x 60 days OR
- Doxycycline 100mg PO q12hrs x 60 days
Cutaneous Anthrax (not systemically ill)
- Ciprofloxacin 500mg PO q12hrs x 60 days
- Doxycycline 100mg PO q12hrs x 60 days
Inhalation or Cutaneous with systemic illness
- Ciprofloxacin 400mg IV q12hrs x 60 days (1st line) OR
- Doxycycline 100mg IV q12hrs x 60days (only if allergic to ciprofloxacin) PLUS
- Clindamycin 900mg IV q8hrs
Pediatric Postexpsoure Prophylaxis
- Ciprofloxacin 15mg/kg PO q12hrs x 60 days
- Doxycycline 2.2mg/kg PO q12hrs x 60 days
Pediatric Cutaneous Anthrax (not ill)
- Same as post exposure dosing and duration
Pediatric Inhalational or Cutaneous (systemically ill
- Ciprofloxacin 15mg/kg IV q12hrs (1st line) OR
- Doxycycline 2.2mg/kg IV q12hrs (only if allergic to cipro) PLUS
- Clindamycin 7.5mg/kg q6hrs daily